Kennedy Capital Management’s Acceleron Pharma Inc. XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-20,408
| Closed | -$3.51M | – | 665 |
|
|
2021
Q3 | $3.51M | Sell |
20,408
-5,325
| -21% | -$916K | 0.08% | 409 |
|
|
2021
Q2 | $3.23M | Buy |
25,733
+241
| +0.9% | +$30.2K | 0.07% | 434 |
|
|
2021
Q1 | $3.46M | Sell |
25,492
-18,245
| -42% | -$2.47M | 0.07% | 443 |
|
|
2020
Q4 | $5.6M | Buy |
43,737
+1,356
| +3% | +$173K | 0.13% | 312 |
|
|
2020
Q3 | $4.77M | Sell |
42,381
-224
| -0.5% | -$25.2K | 0.14% | 286 |
|
|
2020
Q2 | $4.06M | Sell |
42,605
-2,020
| -5% | -$192K | 0.12% | 333 |
|
|
2020
Q1 | $4.01M | Sell |
44,625
-1,972
| -4% | -$177K | 0.15% | 258 |
|
|
2019
Q4 | $2.47M | Sell |
46,597
-50,757
| -52% | -$2.69M | 0.06% | 508 |
|
|
2019
Q3 | $3.85M | Sell |
97,354
-18,411
| -16% | -$727K | 0.1% | 401 |
|
|
2019
Q2 | $4.76M | Sell |
115,765
-905
| -0.8% | -$37.2K | 0.11% | 343 |
|
|
2019
Q1 | $5.43M | Buy |
+116,670
| New | +$5.43M | 0.13% | 303 |
|
|
2015
Q2 | – | Sell |
-23,762
| Closed | -$904K | – | 764 |
|
|
2015
Q1 | $904K | Buy |
23,762
+3,594
| +18% | +$137K | 0.02% | 661 |
|
|
2014
Q4 | $786K | Buy |
+20,168
| New | +$786K | 0.01% | 684 |
|